 LAVAL, QC and CAMBRIDGE, England, May 21, 2021 PRNewswire - Liminal BioSciences Inc. Nasdaq: LMNL Liminal BioSciences or the Company, a clinical-stage biopharmaceutical company, announced today that it has closed on the previously announced divestment of its 2 plasma collection centers, Prometic Plasma Resources Inc. and Prometic Plasma Resources USA Inc. collectively, PPRs to Kedrion S.p.A. Kedrion. 